Obesity and Cancer Mechanisms: Cancer Metabolism
Data up to Jan 2025
Total Citations Per Year
Abstract
References (124)
The Hallmarks of Cancer
2000 • 27,569 citations
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 • 13,873 citations
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
2014 • 7,830 citations
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 • 7,305 citations
Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
2012 • 5,369 citations
Leptin and the regulation of body weight in mammals
1998 • 5,366 citations
Cellular mechanisms of insulin resistance
2000 • 2,692 citations
Cancer Cell Metabolism: Warburg and Beyond
2008 • 2,255 citations
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 • 2,226 citations
Insulin and insulin-like growth factor signalling in neoplasia
2008 • 1,927 citations
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 • 1,906 citations
Estrogen Carcinogenesis in Breast Cancer
2006 • 1,780 citations
The insulin signaling system.
1994 • 1,733 citations
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
2011 • 1,608 citations
Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies
2012 • 1,527 citations
Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults
2014 • 1,515 citations
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
2007 • 1,422 citations
The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial
2008 • 1,108 citations
The insulin and insulin-like growth factor receptor family in neoplasia: an update
2012 • 1,034 citations
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
2002 • 1,002 citations
New Users of Metformin Are at Low Risk of Incident Cancer
2009 • 974 citations
Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling
1993 • 972 citations
Exercise for overweight or obesity
2006 • 941 citations
Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells
1999 • 865 citations
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
2013 • 764 citations
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
2003 • 740 citations
Adipose tissue and adipocytes support tumorigenesis and metastasis
2013 • 681 citations
Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
2011 • 670 citations
Causes of death in cancer patients
1974 • 597 citations
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
1998 • 592 citations
Leptin and cancer
2005 • 572 citations
Activation of phosphatidylinositol 3-kinase by insulin.
1990 • 531 citations
Androgen receptor signaling in prostate cancer development and progression
2011 • 484 citations
Obesity and Breast Cancer: The Estrogen Connection
2009 • 459 citations
An SH3-SH2-SH3 protein is required for p21Ras1 activation and binds to sevenless and Sos proteins in vitro
1993 • 451 citations
Tumours with PI3K activation are resistant to dietary restriction
2009 • 448 citations
Insulin signaling meets mitochondria in metabolism
2010 • 401 citations
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
2008 • 395 citations
Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity
2008 • 388 citations
A high-fat, ketogenic diet induces a unique metabolic state in mice
2007 • 387 citations
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
2002 • 370 citations
The role of protein in weight loss and maintenance
2015 • 357 citations
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
2015 • 350 citations
Discovery of Canagliflozin, a Novel C-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
2010 • 348 citations
Minireview: IGF, Insulin, and Cancer
2011 • 333 citations
Elevated insulin receptor content in human breast cancer.
1990 • 332 citations
Quantitative Mass Spectrometry Identifies Insulin Signaling Targets in C. elegans
2007 • 324 citations
SGLT inhibitors in management of diabetes
2013 • 309 citations
A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors
2014 • 293 citations
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
2016 • 283 citations
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
2011 • 278 citations
Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2014 • 265 citations
Adipocytokines and cancer
2006 • 262 citations
IGF2 and cancer
2013 • 260 citations
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer
2009 • 250 citations
ERGO: A pilot study of ketogenic diet in recurrent glioblastoma
2014 • 245 citations
Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact
2016 • 243 citations
Energy Balance, Host-Related Factors, and Cancer Progression
2010 • 238 citations
Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
2012 • 232 citations
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
2012 • 232 citations
Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
2010 • 227 citations
Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer
2005 • 220 citations
Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases
2007 • 211 citations
Leptin-induced Growth Stimulation of Breast Cancer Cells Involves Recruitment of Histone Acetyltransferases and Mediator Complex to CYCLIN D1 Promoter via Activation of Stat3
2007 • 199 citations
Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme
2014 • 198 citations
Adiponectin as a growth inhibitor in prostate cancer cells
2005 • 196 citations
Effects of adiponectin on breast cancer cell growth and signaling
2008 • 195 citations
Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients
2012 • 185 citations
Prostate Cancer Cell-Adipocyte Interaction
2003 • 182 citations
Obesity, Energy Balance, and Cancer: New Opportunities for Prevention
2012 • 170 citations
Does intentional weight loss reduce cancer risk?
2011 • 168 citations
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
2015 • 162 citations
Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade
2015 • 157 citations
Androgens and obesity
2010 • 149 citations
Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis
2015 • 133 citations
Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer
2013 • 131 citations
Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
2014 • 130 citations
Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
2015 • 124 citations
Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95–2
2007 • 121 citations
Interaction between Adiponectin and Leptin Influences the Risk of Colorectal Adenoma
2010 • 117 citations
Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRASG12D-driven lung tumors
2013 • 112 citations
Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
2015 • 106 citations
Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc ( Min/+ ) colon epithelial cell line
2006 • 103 citations
Stromal Estrogen Receptor-α Promotes Tumor Growth by Normalizing an Increased Angiogenesis
2012 • 100 citations
Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition
2007 • 100 citations
Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer
2014 • 98 citations
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
2013 • 98 citations
Insulin receptor expression and clinical outcome in node-negative breast cancer.
1997 • 94 citations
Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a low-carbohydrate ketogenic diet
2015 • 92 citations
Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors
2014 • 91 citations
Leptin activation of mTOR pathway in intestinal epithelial cell triggers lipid droplet formation, cytokine production and increased cell proliferation
2015 • 87 citations
Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
2015 • 86 citations
Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes
2012 • 86 citations
Expression of insulin-like growth factor 2 in mesenchymal neoplasms
2009 • 82 citations
Measuring the biological effect of presurgical metformin treatment in endometrial cancer
2016 • 79 citations
Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia
2011 • 76 citations
Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer
2016 • 72 citations
Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy
2016 • 71 citations
Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer
2014 • 70 citations
Mitochondrial free fatty acid β-oxidation supports oxidative phosphorylation and proliferation in cancer cells
2015 • 65 citations
Obesity and Cortisol Status
2005 • 65 citations
Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2
2012 • 64 citations
Highly specific role of the insulin receptor in breast cancer progression
2015 • 64 citations
Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II
2011 • 63 citations
Metformin and trametinib have synergistic effects on cell viability and tumor growth inNRASmutant cancer
2014 • 63 citations
Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis
2015 • 61 citations
Altered Expression of Insulin Receptor Isoforms in Breast Cancer
2011 • 58 citations
The effects of the ketogenic diet in refractory partial seizures with reference to tuberous sclerosis
2006 • 55 citations
Metformin and erlotinib synergize to inhibit basal breast cancer
2014 • 55 citations
Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett’s Esophagus
2014 • 46 citations
Acyl-Coenzyme A–Binding Protein Regulates Beta-Oxidation Required for Growth and Survival of Non–Small Cell Lung Cancer
2014 • 45 citations
Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas
2015 • 43 citations
Mechanisms of energy restriction: effects of corticosterone on cell growth, cell cycle machinery, and apoptosis.
2002 • 42 citations
Energy balance modulates colon tumor growth: Interactive roles of insulin and estrogen
2010 • 38 citations
Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes
2010 • 38 citations
Metformin and Gynecologic Cancers
2014 • 33 citations
Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma
2016 • 32 citations
Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma
2014 • 30 citations
Role of genomic imprinting in Wilms' tumour and overgrowth disorders
1996 • 28 citations
Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial
2015 • 28 citations
Mechanisms linking obesity to altered metabolism in mice colon carcinogenesis
2015 • 28 citations
Metformin: risk-benefit profile with a focus on cancer
2015 • 18 citations
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)
2015 • 13 citations
Proteomic modulation in breast tumors after metformin exposure: results from a “window of opportunity” trial
2016 • 10 citations
Cited By (0)
No citing papers found in database